Toxic epidermal necrolysis after mifepristone/gemeprost-induced abortion

Journal of the American Academy of Dermatology

Volumn 35, Issue 1, 1996, Pages 112-

  Lecorvaisier Pieto, C ^a   Joly, P ^a   Thomine, E ^a   Tanasescu, S ^a   Noblet, C ^b   Lauret, Ph ^a  

^a HÔPITAL CHARLES NICOLLE   (France)

^b Dept de Médecine Interne Ctr Hosp Univ Rouen Boisguillaume   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ABORTIVE AGENT; GEMEPROST; MIFEPRISTONE; PROSTAGLANDIN DERIVATIVE;

ADULT; ARTICLE; CASE REPORT; DISEASE SEVERITY; DRUG INDUCED DISEASE; DRUG MIXTURE; FEMALE; HUMAN; HUMAN TISSUE; INDUCED ABORTION; INTRAVAGINAL DRUG ADMINISTRATION; ORAL DRUG ADMINISTRATION; PREGNANCY TERMINATION; PRIORITY JOURNAL; SKIN BIOPSY; SKIN DISEASE; TOXIC EPIDERMAL NECROLYSIS;

EID: 15844389655     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0190-9622(96)90520-4     Document Type: Article

References (4)

1. Silvestre S, Dubois C, Renault M, et al. Voluntary interruption of pregnancy with mifepristone (RU 486) and a prostaglandin analogue: a large-scale French experience. N Engl J Med 1990;322:645-8.
2. Roujeau JC, Stern RS. Severe adverse cutaneous reactions to drugs. N Engl J Med 1994;10:1272-85.
3. Laue L, Lotze MT, Chrousos GP, et al. Effect of chronic treatment with the glucocorticoid antagonist RU 486 in man: toxicity, immunological and hormonal aspects. J Clin Endocrinol Metab 1990;71:1474-80.
4. Delay M, Genestal M, Carrie D, et al. Arrêt cardio-circulatoire après administration de l'association mifépristone (MIFEGYNE) sulprostone (NALADOR) pour interruption de grossesse. Arch Mal Coeur 1992;85:105-7.